Matrix metalloproteinase 14 modulates diabetes and Alzheimer’s disease cross-talk: a meta-analysis
- 258 Downloads
Diabetes mellitus is associated with dementia, but whether diabetes is associated with Alzheimer’s disease remains controversial. Alzheimer’s disease is characterized by amyloid beta aggregation. We hypothesized that genes, involved in amyloid beta degradation, may be altered due to diabetes and thus participate in progression of Alzheimer’s disease. Expression profiling of amyloid beta-degrading enzymes in streptozotocin-induced diabetic mice and their correlation with expression of amyloid precursor protein in hippocampus of Alzheimer’s disease patients were accessed. We found that matrix metalloproteinase 14 decreased in brain but not in other tissues of streptozotocin-induced diabetic mice, and was negatively correlated with expression of amyloid precursor protein in hippocampus of Alzheimer’s disease patients. These findings suggested matrix metalloproteinase 14 may link insulin-deficient diabetes to Alzheimer’s disease.
KeywordsDiabetes Alzheimer’s disease Mmp14 Association
Conceptualization, J.C and H.-P.L.; Methodology, J.C and H.-P.L.; Investigation, J.C and C.-C. L.; Writing—Original Draft, J.C and C.-C. L.; Writing—Review and Editing, M.-Y.C., W.-Y.L. and H.-P.L.; Funding Acquisition, W.-Y.L. and F.-J.T.; Resources, W.-Y.L. and F.-J.T.; Supervision, F.-J.T.
This work was supported by grants from the Ministry of Science and Technology in Taiwan (MOST105-2632-B-039-002, MOST 104-2320-B-039-009) and grants from China Medical University & Hospital (CMU105-S-39, DMR-101-065, DMR-105-085, CMU98-CT-25). This study is also supported in part by the Brain Diseases Research Center at China Medical University (BDRC 2017), and Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Hofman A (2000) Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 54(11 Suppl 5):S10–S15PubMedGoogle Scholar
- 5.Coco M, Caggia S, Musumeci G, Perciavalle V, Graziano AC, Pannuzzo G, Cardile V (2013) Sodium L-lactate differently affects brain-derived neurothrophic factor, inducible nitric oxide synthase, and heat shock protein 70 kDa production in human astrocytes and SH-SY5Y cultures. J Neurosci Res 91(2):313–320CrossRefPubMedGoogle Scholar
- 9.Abner EL, Nelson PT, Kryscio RJ, Schmitt FA, Fardo DW, Woltjer RL, Masaki K (2016) Diabetes is associated with cerebrovascular but not Alzheimer neuropathology. Alzheimer’s DementGoogle Scholar
- 15.Vagelatos NT, Eslick GD (2013) Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev, mxs012Google Scholar
- 18.Morales-Corraliza J, Wong H, Mazzella MJ, Che S, Lee SH, Petkova E, Mathews PM (2016) Brain-wide insulin resistance, tau phosphorylation changes, and hippocampal neprilysin and amyloid-β alterations in a monkey model of type 1 diabetes. J Neurosci 36(15):4248–4258CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Ito S, Ohtsuki S, Murata S, Katsukura Y, Suzuki H, Funaki M, Terasaki T (2014) Involvement of insulin-degrading enzyme in insulin-and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells. J Alzheimers Dis 38(1):185–200PubMedGoogle Scholar
- 29.Khokha R, Denhardt DT (1988) Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 9(6):391–405Google Scholar
- 41.Asahina M, Yoshiyama Y, Hattori T (2000) Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer’s disease brain. Clin Neuropathol 20(2):60–63Google Scholar
- 66.Silva JA, Ferrucci DL, Peroni LA, Abrahao PG, Salamene AF, Rossa-Junior C, Stach-Machado DR (2012) Sequential IL-23 and IL-17 and increased Mmp8 and Mmp14 expression characterize the progression of an experimental model of periodontal disease in type 1 diabetes. J Cell Physiol 227(6):2441–2450CrossRefPubMedGoogle Scholar
- 78.Tinahones FJ, Coín-Aragüez L, Mayas MD, Garcia-Fuentes E, Hurtado-del-Pozo C, Vendrell J, El Bekay R (2012) Obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels. BMC Physiol 12(1):4CrossRefPubMedPubMedCentralGoogle Scholar
- 82.Fukumoto H, Asami-Odaka A, Suzuki N, Shimada H, Ihara Y, Iwatsubo T (1996) Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer’s disease. predominance of A beta 42 (43) and association of A beta 40 with cored plaques. Am J Pathol 148(1):259PubMedPubMedCentralGoogle Scholar